G-CSF stimulated bone marrow versus conventional bone marrow as stem cell source in matched sibling donor transplantation
Paediatric leukaemias · Myelodysplastic Syndromes
Enrolment: 27 · Results not recorded
Biologic · Granulocyte colony stimulating factor receptor agonist (AGONIST; direct interaction)
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Paediatric leukaemias · Myelodysplastic Syndromes
Enrolment: 27 · Results not recorded
Lymphoma
Enrolment: 7 · Results not recorded
Acute Myeloid Leukemia
Enrolment: 50 · Results not recorded
Cytokines
Enrolment: 35 · Results not recorded
Leukemia
Enrolment: 30 · Results not recorded
Breast Cancer · Neutropenia
Enrolment: 189 · Results not recorded
Solid Tumours · Chemotherapy-Induced Neutropenia
Enrolment: 132 · Results not recorded
Chemotherapy-Induced Neutropenia
Enrolment: 80 · Results not recorded
Chemotherapy-Induced Neutropenia
Enrolment: 9 · Results not recorded
Sarcoma
Enrolment: 38 · Results not recorded
Lymphoma
Enrolment: 34 · Results not recorded
Cerebral Palsy
Enrolment: 88 · Results not recorded
Metastatic Prostate Neuroendocrine Carcinoma · Metastatic Prostate Cancer
Enrolment: 41 · Results not recorded
Malignant Lymphoma
Enrolment: 32 · Results not recorded
Non-Hodgkin's Lymphoma
Enrolment: 25 · Results not recorded
Breast Cancer
Enrolment: 0 · Results not recorded
Breast Cancer
Enrolment: 31 · Results not recorded
Multiple Myeloma
Enrolment: 7 · Results not recorded
Myasthenia Gravis
Enrolment: 9 · Results not recorded
Leukemia · Lymphoma
Enrolment: 5 · Results not recorded
15 studies reported at therapy level; 16 evidence entries itemised.
Model: Creation of a full-thickness supraspinatus tendon defect with immediate surgical repair
G-CSF significantly increased the cellularity composite score versus control at 12 days (7.40 plus or minus 1.14 versus 4.50 plus or minus 0.57, p = 0.038) and 19 days (8.00 plus or minus 1.00 versus 5.40 plus or minus 0.89, p = 0.023). No differences were seen in any biomechanical property or MRI…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Gastrointestinal acute radiation syndrome induced by 10 Gy whole-body gamma irradiation
Alpha-tocopherol succinate alone reduced malondialdehyde and normalised glutathione, whereas filgrastim alone did not affect these oxidative markers; both lowered myeloperoxidase and IL-1beta. The combination markedly increased glutathione, raised serum citrulline by 94%, reduced epithelial damage…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Unilateral acid instillation producing severe but survivable acute lung injury with features of the acute respiratory distress syndrome
Neutrophil depletion with Ly6G antibody impaired type II pneumocyte proliferation and re-epithelialisation and increased alveolar protein concentration. Neutropenic G-CSF knockout mice showed the same defective repair, which was reversed by administration of exogenous G-CSF, indicating that neutrop…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Moderate controlled cortical impact traumatic brain injury; craniectomy about 2.5 mm radius at +0.2 mm anterior and -0.2 mm lateral right of bregma, impact to fronto-parietal cortex at 6.0 m/s to 1.0 mm below dura, 150 ms dwell, impactor angled 15 degrees
Combined hUCB plus G-CSF robustly dampened neuroinflammation, enhanced endogenous neurogenesis, reduced hippocampal cell loss and produced long-lasting motor recovery to day 56. hUCB monotherapy gave intermediate benefit, while G-CSF monotherapy produced only partial and short-lived motor benefit t…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.
Model: Neonatal hypoxic-ischaemic brain injury
G-CSF did not improve neurobehavioural outcomes or brain injury after neonatal hypoxia-ischaemia, and acute-phase injection increased hippocampal damage.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Spinal cord hemisection
G-CSF accelerated autophagy activation in injured spinal cord and protected neuronal structure by inhibiting NF-kappaB signalling; blocking autophagy with 3-methyladenine partially removed the neuroprotective effect.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.
Model: 70% partial hepatectomy followed by lipopolysaccharide administration
G-CSF pretreatment worsened outcome. All rats given G-CSF plus lipopolysaccharide plus partial hepatectomy died within 4 h with severe inflammation, erythrocyte congestion, neutrophil infiltration, portal hypertension and pronounced microcirculatory disturbance, against 30% 24 h survival for lipopo…
Extraction: extract · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.
Model: Spinal cord hemisection, with an in vitro neuronal mechanical injury model
G-CSF promoted locomotor recovery and inhibited neuronal apoptosis, and the nucleophosmin 1 inhibitor partially blocked its neuroprotective effect in vitro.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Mouse spinal cord hemisection; parallel in vitro work in BV2 microglia
G-CSF recruited microglia to the injury site during the first 72 hours, inhibited pro-inflammatory factor expression, promoted neurotrophic factor expression and favoured M2 over M1 polarisation of microglia, with NF-kappaB signalling implicated in the polarisation response.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Sublethal total body gamma irradiation, single dose of 600 cGy (6 Gy) delivered at 187 cGy/min from a cobalt source (GWXJ80 Theratron)
G-CSF accelerated thymic and peripheral T cell reconstitution after 6 Gy total body irradiation, with higher thymocyte numbers at days 14 to 28, earlier recovery of CD4+CD8+ double-positive thymocytes (day 28 versus day 60 in controls), higher sjTREC frequency at day 30, shortened severe lymphopeni…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.
Model: Two-kidney one-clip (2K1C) left renal artery clipping causing renal ischaemia and infarction
G-CSF lowered arterial pressure (129 vs 150 mmHg), prevented the rise in plasma angiotensins, reduced ischaemic kidney atrophy and prevented infarction in 7 of 8 mice.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Severe contusive spinal cord injury
Delayed G-CSF increased preserved spinal cord area, improved sensory and motor function, reduced myelin detachment and disruption with axonal sprouting, and lowered microglial and macrophage numbers, while brain-derived neurotrophic factor levels were comparable between groups.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.78. Machine-extracted fields require source verification.
Model: Laminectomy with moderate contusion spinal cord injury at T10 using an NYU impactor, 10 g rod dropped from 12.5 mm, compressing the cord for 15 s; follow-up to 42 days
The combination of G-CSF and methylprednisolone produced greater locomotor recovery than either agent alone or no treatment from day 14 onwards, with a 5.44 point BBB advantage over control at day 42 (p<0.001), and synergistic histological improvement in hyperaemia and cellular infiltration. Motor…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.
Model: Bilateral total-body irradiation from a cobalt-60 gamma source at a midline dose rate of 0.6 Gy/min; LD70/30 doses of 7.8-8.0 Gy (C3H/HeN), 8.0-8.2 Gy (C57BL/6), 8.5 Gy (B6C3F1) and 9.25 Gy (CD2F1); sublethal haematology doses of 6.5 Gy and 7 Gy
Three daily subcutaneous doses of 0.17 mg/kg filgrastim starting 24 h after lethal total-body irradiation raised 30-day survival in all four strains and accelerated haematopoietic recovery, whereas the conventional 16-day schedule failed to improve survival in three of four strains and efficacy was…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.
Model: Full-thickness tail wounds in mice with dorsally implanted polyvinyl alcohol sponges, plus green fluorescent protein bone marrow chimeric mice for homing studies; proof of principle in one patient with a nonhealing venous ulcer
Systemic GCSF mobilised bone marrow stem cells into the peripheral blood and to the wound site, and was associated with increased collagen accumulation and promising wound bed preparation and healing, including in a patient with a nonhealing venous ulcer. No quantitative effect sizes were reported…
Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.